T11	B-Entity	B-Entity	0	3	SRC	SRC	B-NP	NN	B-protein	9	NMOD	B-protein
T11	I-Entity	I-Entity	3	4	-	-	O	HYPH	O	1	P	O
T11	I-Entity	I-Entity	4	11	related	relate	B-NP	VBN	O	9	NMOD	O
T11	I-Entity	I-Entity	12	17	proto	proto	I-NP	AFX	B-DNA	6	NMOD	B-DNA
T11	I-Entity	I-Entity	17	18	-	-	I-NP	HYPH	I-DNA	6	NMOD	I-DNA
T11	I-Entity	I-Entity	18	27	oncogenes	oncogene	B-NP	NNS	I-DNA	9	NMOD	I-DNA
O	O	O	28	31	and	and	O	CC	O	9	NMOD	O
O	O	O	32	45	transcription	transcription	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	46	53	factors	factor	I-NP	NNS	I-protein	16	NMOD	I-protein
O	O	O	54	56	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	57	64	primary	primary	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	65	70	human	human	I-NP	JJ	I-cell_type	14	NMOD	I-cell_type
O	O	O	71	72	T	T	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	73	78	cells	cell	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	O	78	79	:	:	O	:	O	9	P	O
O	O	O	80	90	modulation	modulation	B-NP	NN	O	0	ROOT	O
O	O	O	91	93	by	by	B-PP	IN	O	16	NMOD	O
O	O	O	94	105	cyclosporin	cyclosporin	B-NP	NN	O	19	NMOD	O
O	O	O	106	107	A	A	I-NP	NN	O	21	NMOD	O
O	O	O	108	111	and	and	I-NP	CC	O	21	NMOD	O
O	O	O	112	117	FK506	FK506	I-NP	NN	O	17	PMOD	O
O	O	O	117	118	.	.	O	.	O	16	P	O

O	O	O	120	130	Activation	Activation	B-NP	NN	O	5	SUB	O
O	O	O	131	133	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	134	135	T	T	B-NP	NN	B-cell_type	4	NMOD	B-cell_type
O	O	O	136	147	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	O	148	155	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	O	156	169	transcription	transcription	B-NP	NN	O	5	OBJ	O
O	O	O	170	172	of	of	B-PP	IN	O	6	NMOD	O
T12	B-Entity	B-Entity	173	178	genes	gene	B-NP	NNS	B-DNA	7	PMOD	B-DNA
O	O	O	179	187	encoding	encode	B-VP	VBG	O	8	NMOD	O
O	O	O	188	191	for	for	B-PP	IN	O	9	VMOD	O
O	O	O	192	203	lymphokines	lymphokine	B-NP	NNS	B-protein	10	PMOD	B-protein
O	O	O	203	204	.	.	O	.	O	5	P	O

T1	B-Protein	B-Protein	205	216	Interleukin	Interleukin	B-NP	NN	B-protein	10	NMOD	B-protein
T1	I-Protein	I-Protein	216	217	-	-	O	HYPH	O	1	P	O
T1	I-Protein	I-Protein	217	218	2	2	B-NP	CD	B-DNA	10	NMOD	B-DNA
O	O	O	219	220	(	(	O	(	I-DNA	10	NMOD	I-DNA
T2	B-Protein	B-Protein	220	222	IL	IL	B-NP	NN	I-DNA	10	NMOD	I-DNA
T2	I-Protein	I-Protein	222	223	-	-	O	HYPH	I-DNA	7	P	I-DNA
T2	I-Protein	I-Protein	223	224	2	2	O	CD	I-DNA	10	NMOD	I-DNA
O	O	O	224	225	)	)	O	)	I-DNA	10	NMOD	I-DNA
O	O	O	226	230	gene	gene	B-NP	NN	I-DNA	10	NMOD	I-DNA
O	O	O	231	241	expression	expression	I-NP	NN	O	11	SUB	O
O	O	O	242	244	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	245	255	controlled	control	I-VP	VBN	O	11	VC	O
O	O	O	256	273	transcriptionally	transcriptionally	B-ADVP	RB	O	12	VMOD	O
O	O	O	274	276	by	by	B-PP	IN	O	12	VMOD	O
O	O	O	277	280	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	281	292	cooperative	cooperative	I-NP	JJ	O	17	NMOD	O
O	O	O	293	301	activity	activity	I-NP	NN	O	14	PMOD	O
O	O	O	302	304	of	of	B-PP	IN	O	17	NMOD	O
O	O	O	305	313	specific	specific	O	JJ	O	23	NMOD	O
O	O	O	314	319	trans	trans	O	AFX	B-protein	23	NMOD	B-protein
O	O	O	319	320	-	-	O	HYPH	I-protein	23	NMOD	I-protein
O	O	O	320	330	activating	activate	B-VP	VBG	I-protein	23	NMOD	I-protein
O	O	O	331	338	factors	factor	B-NP	NNS	I-protein	18	PMOD	I-protein
O	O	O	339	343	that	that	B-NP	WDT	O	23	NMOD	O
O	O	O	344	348	bind	bind	B-VP	VBP	O	24	SBAR	O
O	O	O	349	351	to	to	B-PP	TO	O	25	VMOD	O
O	O	O	352	355	the	the	B-NP	DT	O	31	NMOD	O
T3	B-Protein	B-Protein	356	358	IL	IL	I-NP	NN	B-DNA	31	NMOD	B-DNA
T3	I-Protein	I-Protein	358	359	-	-	B-NP	HYPH	I-DNA	31	NMOD	I-DNA
T3	I-Protein	I-Protein	359	360	2	2	I-NP	CD	I-DNA	31	NMOD	I-DNA
T13	B-Entity	B-Entity	361	369	enhancer	enhancer	I-NP	NN	I-DNA	26	PMOD	I-DNA
O	O	O	369	370	.	.	O	.	O	11	P	O

O	O	O	371	382	Cyclosporin	Cyclosporin	B-NP	NN	O	2	NMOD	O
O	O	O	383	384	A	A	I-NP	NN	O	7	NMOD	O
O	O	O	385	386	(	(	O	(	O	5	DEP	O
O	O	O	386	389	CsA	CsA	B-NP	NN	O	5	DEP	O
O	O	O	389	390	)	)	O	)	O	2	NMOD	O
O	O	O	391	394	and	and	O	CC	O	7	NMOD	O
O	O	O	395	400	FK506	FK506	B-NP	NN	O	8	SUB	O
O	O	O	401	408	inhibit	inhibit	B-VP	VBP	O	0	ROOT	O
O	O	O	409	412	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	413	423	production	production	I-NP	NN	O	8	OBJ	O
O	O	O	424	426	of	of	B-PP	IN	O	10	NMOD	O
T4	B-Protein	B-Protein	427	429	IL	IL	B-NP	NN	B-protein	11	PMOD	B-protein
T4	I-Protein	I-Protein	429	430	-	-	O	HYPH	I-protein	12	NMOD	I-protein
T4	I-Protein	I-Protein	430	431	2	2	B-NP	CD	I-protein	12	NMOD	I-protein
O	O	O	432	434	in	in	B-PP	IN	O	10	NMOD	O
O	O	O	435	436	T	T	B-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	O	437	448	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	O	449	451	at	at	B-PP	IN	O	8	VMOD	O
O	O	O	452	455	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	456	461	level	level	I-NP	NN	O	18	PMOD	O
O	O	O	462	464	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	465	469	gene	gene	B-NP	NN	O	23	NMOD	O
O	O	O	470	483	transcription	transcription	I-NP	NN	O	21	PMOD	O
O	O	O	483	484	.	.	O	.	O	8	P	O

O	O	O	485	486	A	A	B-NP	DT	O	2	NMOD	O
O	O	O	487	493	member	member	I-NP	NN	O	17	NMOD	O
O	O	O	494	496	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	497	500	the	the	B-NP	DT	O	7	NMOD	O
T14	B-Entity	B-Entity	501	504	src	src	I-NP	NN	B-DNA	7	NMOD	B-DNA
T14	I-Entity	I-Entity	505	509	gene	gene	I-NP	NN	I-DNA	7	NMOD	I-DNA
T14	I-Entity	I-Entity	510	516	family	family	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	O	516	517	,	,	O	,	O	17	P	O
O	O	O	518	521	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	522	532	lymphocyte	lymphocyte	I-NP	NN	B-protein	15	NMOD	B-protein
O	O	O	532	533	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
O	O	O	533	541	specific	specific	I-NP	JJ	I-protein	15	NMOD	I-protein
O	O	O	542	549	protein	protein	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	550	558	tyrosine	tyrosine	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	559	565	kinase	kinase	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	565	566	,	,	O	,	O	17	P	O
T5	B-Protein	B-Protein	567	573	p56lck	p56lck	B-NP	NN	B-protein	19	SUB	B-protein
O	O	O	573	574	,	,	O	,	O	17	P	O
O	O	O	575	578	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	579	583	been	be	I-VP	VBN	O	19	VC	O
O	O	O	584	594	implicated	implicate	I-VP	VBN	O	20	VC	O
O	O	O	595	597	in	in	B-PP	IN	O	21	VMOD	O
T6	B-Protein	B-Protein	598	600	IL	IL	B-NP	NN	B-protein	26	NMOD	B-protein
T6	I-Protein	I-Protein	600	601	-	-	O	HYPH	I-protein	26	NMOD	I-protein
T6	I-Protein	I-Protein	601	602	2	2	B-NP	CD	I-protein	26	NMOD	I-protein
O	O	O	603	613	production	production	I-NP	NN	O	22	PMOD	O
O	O	O	613	614	.	.	O	.	O	19	P	O

O	O	O	615	618	CsA	CsA	B-NP	NN	O	2	SUB	O
O	O	O	619	622	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	623	628	found	find	I-VP	VBN	O	2	VC	O
O	O	O	629	632	not	not	O	RB	O	6	VMOD	O
O	O	O	633	635	to	to	B-VP	TO	O	6	VMOD	O
O	O	O	636	643	inhibit	inhibit	I-VP	VB	O	3	VMOD	O
T7	B-Protein	B-Protein	644	647	lck	lck	B-NP	NN	B-DNA	9	NMOD	B-DNA
O	O	O	648	652	gene	gene	I-NP	NN	I-DNA	9	NMOD	I-DNA
O	O	O	653	663	expression	expression	I-NP	NN	O	13	NMOD	O
O	O	O	663	664	,	,	O	,	O	13	P	O
O	O	O	665	668	nor	nor	O	CC	O	13	NMOD	O
O	O	O	669	672	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	673	681	activity	activity	I-NP	NN	O	6	OBJ	O
O	O	O	682	684	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	685	688	the	the	B-NP	DT	O	18	NMOD	O
T8	B-Protein	B-Protein	689	692	lck	lck	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	693	697	gene	gene	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	698	705	product	product	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	O	705	706	.	.	O	.	O	2	P	O

O	O	O	707	714	However	However	B-ADVP	RB	O	6	VMOD	O
O	O	O	714	715	,	,	O	,	O	6	P	O
O	O	O	716	719	CsA	CsA	B-NP	NN	O	5	NMOD	O
O	O	O	720	723	and	and	I-NP	CC	O	5	NMOD	O
O	O	O	724	729	FK506	FK506	I-NP	NN	O	6	SUB	O
O	O	O	730	737	inhibit	inhibit	B-VP	VBP	O	0	ROOT	O
O	O	O	738	741	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	742	752	appearance	appearance	I-NP	NN	O	6	OBJ	O
O	O	O	753	755	of	of	B-PP	IN	O	8	NMOD	O
T15	B-Entity	B-Entity	756	759	DNA	DNA	B-NP	NN	O	12	NMOD	O
O	O	O	760	767	binding	binding	I-NP	NN	O	12	NMOD	O
O	O	O	768	776	activity	activity	I-NP	NN	O	9	PMOD	O
O	O	O	777	779	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	780	787	factors	factor	B-NP	NNS	O	13	PMOD	O
O	O	O	788	792	that	that	B-NP	WDT	O	14	NMOD	O
O	O	O	793	797	bind	bind	B-VP	VBP	O	15	SBAR	O
O	O	O	798	800	to	to	B-PP	TO	O	16	VMOD	O
O	O	O	801	804	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	805	807	NF	NF	I-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	807	808	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
O	O	O	808	810	AT	AT	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	811	814	and	and	I-NP	CC	O	26	NMOD	O
O	O	O	815	817	AP	AP	I-NP	NN	B-DNA	26	NMOD	B-DNA
O	O	O	817	818	-	-	B-NP	HYPH	I-DNA	26	NMOD	I-DNA
O	O	O	818	819	1	1	I-NP	CD	I-DNA	26	NMOD	I-DNA
T16	B-Entity	B-Entity	820	825	sites	site	I-NP	NNS	I-DNA	17	PMOD	I-DNA
O	O	O	826	828	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	829	832	the	the	B-NP	DT	O	32	NMOD	O
T9	B-Protein	B-Protein	833	835	IL	IL	I-NP	NN	B-DNA	32	NMOD	B-DNA
T9	I-Protein	I-Protein	835	836	-	-	I-NP	HYPH	I-DNA	32	NMOD	I-DNA
T9	I-Protein	I-Protein	836	837	2	2	I-NP	CD	I-DNA	32	NMOD	I-DNA
T17	B-Entity	B-Entity	838	846	enhancer	enhancer	I-NP	NN	I-DNA	27	PMOD	I-DNA
O	O	O	846	847	.	.	O	.	O	6	P	O

O	O	O	848	853	Since	Since	B-SBAR	IN	O	27	VMOD	O
O	O	O	854	857	the	the	B-NP	DT	O	3	NMOD	O
O	O	O	858	867	induction	induction	I-NP	NN	O	12	SUB	O
O	O	O	868	870	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	871	873	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	873	874	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
O	O	O	874	876	AT	AT	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	O	877	880	and	and	I-NP	CC	O	10	NMOD	O
T18	B-Entity	B-Entity	881	883	AP	AP	I-NP	NN	B-protein	10	NMOD	B-protein
T18	I-Entity	I-Entity	883	884	-	-	B-NP	HYPH	I-protein	4	PMOD	I-protein
T18	I-Entity	I-Entity	884	885	1	1	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	O	886	888	is	be	B-VP	VBZ	O	1	SBAR	O
O	O	O	889	896	induced	induce	I-VP	VBN	O	12	VC	O
O	O	O	897	899	by	by	B-PP	IN	O	13	VMOD	O
O	O	O	900	903	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	904	908	same	same	I-NP	JJ	O	17	NMOD	O
O	O	O	909	916	stimuli	stimulus	I-NP	NNS	O	14	PMOD	O
O	O	O	917	921	that	that	B-NP	WDT	O	17	NMOD	O
O	O	O	922	931	stimulate	stimulate	B-VP	VBP	O	18	SBAR	O
T10	B-Protein	B-Protein	932	934	IL	IL	B-NP	NN	B-protein	23	NMOD	B-protein
T10	I-Protein	I-Protein	934	935	-	-	O	HYPH	I-protein	20	NMOD	I-protein
T10	I-Protein	I-Protein	935	936	2	2	B-NP	CD	I-protein	23	NMOD	I-protein
O	O	O	937	947	production	production	I-NP	NN	O	19	OBJ	O
O	O	O	947	948	,	,	O	,	O	27	P	O
O	O	O	949	954	these	these	B-NP	DT	O	26	NMOD	O
O	O	O	955	962	results	result	I-NP	NNS	O	27	SUB	O
O	O	O	963	971	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	972	976	that	that	B-SBAR	IN	O	27	VMOD	O
O	O	O	977	980	the	the	B-NP	DT	O	31	NMOD	O
O	O	O	981	998	immunosuppressant	immunosuppressant	I-NP	JJ	O	31	NMOD	O
O	O	O	999	1005	action	action	I-NP	NN	O	36	SUB	O
O	O	O	1006	1008	of	of	B-PP	IN	O	31	NMOD	O
O	O	O	1009	1012	CsA	CsA	B-NP	NN	O	35	NMOD	O
O	O	O	1013	1016	and	and	I-NP	CC	O	35	NMOD	O
O	O	O	1017	1022	FK506	FK506	I-NP	NN	O	32	PMOD	O
O	O	O	1023	1025	is	be	B-VP	VBZ	O	28	SBAR	O
O	O	O	1026	1033	exerted	exert	I-VP	VBN	O	36	VC	O
O	O	O	1034	1036	at	at	B-PP	IN	O	37	VMOD	O
O	O	O	1037	1040	the	the	B-NP	DT	O	40	NMOD	O
O	O	O	1041	1046	level	level	I-NP	NN	O	38	PMOD	O
O	O	O	1047	1049	of	of	B-PP	IN	O	40	NMOD	O
O	O	O	1050	1055	these	these	B-NP	DT	O	46	NMOD	O
O	O	O	1056	1061	trans	trans	I-NP	AFX	B-protein	46	NMOD	B-protein
O	O	O	1061	1062	-	-	I-NP	HYPH	I-protein	46	NMOD	I-protein
O	O	O	1062	1072	activating	activate	B-VP	VBG	I-protein	46	NMOD	I-protein
O	O	O	1073	1080	factors	factor	B-NP	NNS	I-protein	41	PMOD	I-protein
O	O	O	1080	1081	.	.	O	.	O	27	P	O
